Embed Notice

HTML Code

<blockquote style="position: relative; padding-left: 55px;"><section><a href="https://mas.to/users/AkrSakr/statuses/109487750191824502">AkrSakr (akrsakr@mas.to)'s status on Saturday, 10-Dec-2022 14:34:46 JST</a><a href="https://mas.to/@AkrSakr" title="akrsakr@mas.to"><img src="https://gnusocial.jp/avatar/15743-48-20221102022146.webp" width="48" height="48" alt="AkrSakr" style="position: absolute; left: 0; top: 0;">AkrSakr</a></section><article><p>Good news for those who suffer from atopic dermatitis: a strange-name substance called rocatinlimab reduces out-of-control inflammation by acting on an immune molecule called OX40.</p><p>アトピー皮膚炎に苦しむ人に朗報かも。rocatinlimab という耳慣れぬ名の物質が OX40 という人の免疫に関わる分子に効いて暴走する炎症を抑えるそうな</p><p><a href="https://medicalxpress.com/news/2022-12-treatment-moderate-severe-atopic-dermatitis.html" rel="nofollow noreferrer">https://medicalxpress.com/news/2022-12-treatment-moderate-severe-atopic-dermatitis.html</a></p></article><footer><a rel="bookmark" href="https://gnusocial.jp/conversation/816856#notice-1474524">In conversation</a><time datetime="2022-12-10T14:34:46+09:00" title="Saturday, 10-Dec-2022 14:34:46 JST">Saturday, 10-Dec-2022 14:34:46 JST</time> <span>from <span><a href="https://mas.to/@AkrSakr/109487750191824502" rel="external" title="Sent from mas.to via ActivityPub">mas.to</a></span></span><a href="https://mas.to/@AkrSakr/109487750191824502">permalink</a></footer></blockquote>

Corresponding Notice

Embed this notice
AkrSakr (akrsakr@mas.to)'s status on Saturday, 10-Dec-2022 14:34:46 JST AkrSakr
Good news for those who suffer from atopic dermatitis: a strange-name substance called rocatinlimab reduces out-of-control inflammation by acting on an immune molecule called OX40.
アトピー皮膚炎に苦しむ人に朗報かも。rocatinlimab という耳慣れぬ名の物質が OX40 という人の免疫に関わる分子に効いて暴走する炎症を抑えるそうな
https://medicalxpress.com/news/2022-12-treatment-moderate-severe-atopic-dermatitis.html
In conversationSaturday, 10-Dec-2022 14:34:46 JST from mas.topermalink

Public

Embed Notice

HTML Code

Corresponding Notice